Rallybio Corporation (RLYB) Tops Q3 EPS by 56c
Tweet
Share
E-mailGet Alerts RLYB Hot Sheet
Join SI Premium – FREE
Rallybio Corporation (NASDAQ: RLYB) reported Q3 EPS of $0.36, $0.56 better than the analyst estimate of ($0.20). Revenue for the quarter came in at $200 thousand versus the consensus estimate of $0 .
For earnings history and earnings-related data on Rallybio Corporation (RLYB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Movano (MOVE) Misses Q2 EPS by 195c
- Reading (RDI) Tops Q2 EPS by 4c
- AI/ML Innovations plans $2M private placement on the CSE
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
